When Your Pain Has No Name Yet

TL;DR: Pain that lasts more than 3 months while every test comes back normal is common, and medicine has names and a workup for it. It is not in your head. Pain can come from injured tissue, from damaged nerves, or from a pain system whose volume has been turned up, and that third kind does not show on blood work or scans. Write down where it hurts, when it started, and what makes it better or worse. Gather your old records, or let a doctor request them for you. Then bring the whole story to a doctor who will read it. If pain comes with fever, weight loss, new weakness, or new trouble controlling your bladder or bowels, get seen today.

If you have hurt for months or years while the tests keep coming back normal, and somewhere along the way the explanation on offer became stress, or age, or a suggestion that you think about your body too much, the first thing you should hear from a doctor is that pain like yours is recognized, classified, and studied. In 2021, an estimated 51.6 million American adults, about 1 in 5, were living with chronic pain. A normal test result rules out the causes that test was built to see, and nothing more. The mechanisms standard tests were never built to see have a workup of their own, and walking through it is what this page is for.

Is pain with normal test results a recognized medical problem?

Yes. The World Health Organization's current diagnostic catalog, ICD-11, carries a diagnosis called chronic primary pain: pain in 1 or more regions of the body that has lasted more than 3 months, comes with significant distress or interference with daily life, and is not better accounted for by another condition. Normal tests are compatible with that definition by design, because if another condition explained the pain, the diagnosis would be that condition instead.

Under the older way of filing things, pain could only be a symptom pointing at some other disease, so a person whose workup found no other disease had no place in the chart. The new category corrects the filing problem: the pain itself is the condition, and a treatment plan can be built on that diagnosis without waiting for a different one to appear.

What are the 3 kinds of pain?

Pain medicine sorts pain by mechanism into 3 kinds, nociceptive, neuropathic, and nociplastic, and the third is the one most people have never been told about.

Nociceptive pain is the familiar kind: tissue is injured or inflamed, the nerve endings that detect damage fire, and the alarm is doing what it was built to do, the way a sprained ankle or an arthritic knee hurts. This is the pain the standard toolkit was designed around, and when a scan or a lab test finds the injury, this is the mechanism it found.

Neuropathic pain comes from damage or disease in the nerves themselves, meaning the wiring that carries the signal is what got hurt. It tends to burn, tingle, or jolt like electricity, and it follows the territory of the injured nerve: the band of shingles pain that outlasts the rash, the leg pain of sciatica, the burning feet of diabetic nerve damage.

The third category is newer. In 2017 the International Association for the Study of Pain, the body that maintains the field's definitions, adopted the term nociplastic pain: pain that arises from altered processing of pain signals, without clear tissue damage driving the pain receptors and without evidence of disease in the nerves that carry sensation. Translated, the alarm system itself has changed. A 2021 series in The Lancet describes fibromyalgia, irritable bowel syndrome, and a meaningful share of chronic low back pain as conditions where this mechanism does much of the work. The change is in how the nervous system handles signals, which no routine panel measures, and that is how a person can be both fully tested and undiagnosed.

What is central sensitization?

Central sensitization is the best studied mechanism behind nociplastic pain: nerve cells in the spinal cord and brain become more excitable, so signals from the body get amplified on their way to awareness. Clifford Woolf's review in the journal Pain describes what the amplification looks like in a person: light touch that hurts, called allodynia, tenderness that spreads beyond any injured spot, pain that keeps building while an identical small stimulus repeats, and sensations that continue after the stimulus stops. It can be produced in healthy volunteers in a laboratory, and it shows up on electrophysiology and brain imaging, which makes it a mechanism you can measure and a mechanism a treatment can aim at.

The measurement part deserves its own story. In a 2002 study at the National Institutes of Health, researchers pressed on the thumbnails of 16 people with fibromyalgia and 16 people without it while a scanner watched their brains. At the same pressure, the fibromyalgia group reported more pain, and their scans showed more activation in the regions that process pain. When the pressure was adjusted until both groups reported the same amount of pain, the activation looked similar too, meaning what the patients reported matched what their nervous systems were doing.

An everyday picture helps here. A smoke alarm set too sensitive howls at toast: nothing is burning, the sound is at full volume, and the fix is tuning the alarm. A sensitized pain system works the same way. The loudness of the pain tells you how high the system is set, a normal scan tells you the toast is fine, and neither finding argues with the other. None of this places your pain in your imagination. Sensitization is nervous system physiology, and the treatments that help are aimed at the physiology.

Guidance from the Clinic

What does a careful workup for unexplained pain look like?

It starts with the history read start to finish, then an examination done with your story in mind, then tests chosen by your pattern, and every result, normal or abnormal, narrows the map. The history carries more diagnostic weight than any panel here: when the pain started and what else was happening in your health that season, whether it began after an infection you never fully recovered from, what makes it better or worse, how you sleep, and what every treatment so far did or did not do. Where the pain lives matters as much as when it began. A pain that stays in one spot, like chest wall pain you can reproduce by pressing, points differently from a pain that covers a region, and both point differently from pain that has moved across the body. The map itself is a finding.

The examination looks for what no lab can show: joint swelling, strength tested muscle by muscle, reflexes, the borders of any numbness, and how your skin and muscles respond to light touch and gentle pressure. Pain from a touch that should not hurt is allodynia, and it counts as evidence: under the criteria described below, hypersensitivity found on examination is one of the findings that supports a diagnosis.

From there, testing follows the pattern. At Fishtown Medicine the usual sequence includes:

• Inflammation markers. CRP and ESR, 2 blood tests that rise when the immune system is active, screen for the inflammatory family: rheumatoid arthritis, polymyalgia rheumatica, blood vessel inflammation. A normal pair makes that whole family much less likely, which retires a shelf of diagnoses at once. When the story stays strong, repeating the test months later costs little and catches a disease that was early the first time.
• Autoimmune blood tests, when the story fits. An ANA, a screening test for conditions like lupus, earns its place when something beyond pain is present: joint swelling, new rashes, mouth ulcers, dry eyes and mouth, fingers that turn white in the cold. Ordered without any of that, it produces more false alarms than answers, because low-level positives are common in healthy people. A negative result in a fitting story still narrows, making the classic connective tissue diseases unlikely.
• Imaging, when red flags or focal findings call for it. A focal finding means something the examination can point to, like weakness in one muscle group or numbness in one nerve's territory. The reason scans are chosen case by case is what they find in people who feel fine: 37% of pain-free 20-year-olds show disc degeneration on MRI, and 96% of pain-free 80-year-olds do. An untargeted scan almost always finds something, and the work is deciding whether the something explains your pain. The American College of Physicians guideline reserves prompt imaging for progressive nerve findings and suspected serious causes, and that is the practice here.
• Small fiber testing, for burning pain with normal nerve tests. The standard nerve conduction study measures the large, insulated fibers, and the thin fibers that carry pain and temperature are invisible to it, so a person with burning feet can pass an EMG while those fibers are thinning. A skin biopsy that counts nerve fiber density is the validated way to see them, and the fuller picture is in small fiber neuropathy.
• Chemistry with a purpose. Thyroid function, since an underactive thyroid causes body-wide aching; vitamin D and calcium; CK, a muscle enzyme, when muscles ache or weaken; ferritin and B12 when fatigue or nerve symptoms travel with the pain. The medication list gets read in the same pass, because statins and several other common prescriptions cause muscle pain that gets blamed on age.

Each normal result on this list closes specific doors by name. That is the difference between being tested and being worked up: a workup knows which doors are closed, which are still open, and which test decides the next step.

What separates "we haven't found it yet" from "there's nothing there"?

A finished workup separates them, and the key fact is that normal tests are compatible with a positive diagnosis. Nociplastic pain is diagnosed by criteria published in the journal Pain in 2021 by an international task force: pain for more than 3 months, in a regional, multifocal, or widespread distribution, that cannot be fully explained by tissue damage or nerve damage, plus hypersensitivity found on examination in the painful region. Meeting all 4 makes the diagnosis "possible." A history of touch or temperature sensitivity in the same region, together with companions like unrefreshing sleep, fatigue, or brain fog, raises it to "probable." The task force stopped there on purpose: no everyday clinical test yet confirms altered pain processing, so the grading goes no higher than probable, and the criteria say so.

That structure changes what normal results mean. "We have not found it yet" describes an unfinished workup: doors still open, a history nobody has read end to end, patterns nobody has examined. "There is nothing there" is a sentence medicine can almost never say, and a doctor who has finished the list above does not need it. What can be said instead is specific and useful: the dangerous, inflammatory, and structural causes have been checked by name, and the pattern that remains fits a sensitized pain system, which is a diagnosis with criteria and a treatment path.

The categories also overlap, and the overlap matters for treatment. The Lancet series describes nociplastic mechanisms running alongside the other 2, so a person with rheumatoid arthritis can have quiet joints on every marker and still hurt, because the pain system's volume rose during the years of inflammation. Both mechanisms then need attention. A nociplastic diagnosis is also never a door that locks behind you: follow-up keeps watching, and new swelling, new weakness, unintended weight loss, or a change in the pattern reopens targeted testing without debate.

How does Fishtown Medicine approach pain that has no name yet?

With time, belief, and a sequence. Retelling a long story is its own kind of tired, and the intake respects that: write as much or as little as you have in you, upload the records you already hold, or connect with the practice and the records get requested on your behalf, so the story does not have to be told again from the top. Dr. Ash reads everything that arrives before you ever talk, and the first conversation starts where the open questions are.

The workup above runs in sequence over visits, ordered by what your pattern makes most likely, with each result read against your story instead of against a reference range alone. When a piece needs a specialist, like neurology for a skin biopsy or rheumatology when blood tests and symptoms disagree, the referral goes out with the groundwork attached, and the results come back to Dr. Ash, who reads every one himself.

Treatment does not wait for the last result. Sleep gets repaired first when it is broken, because poor sleep and pain amplify each other. Movement is prescribed at a dose your system can hold and raised slowly. When medication fits, it is aimed at the mechanism, and the options for a sensitized system differ from the options for an inflamed joint. 2 expectations belong at the start: no single test proves or disproves a sensitized pain system, so any clinic selling a definitive one is ahead of the evidence, and progress usually arrives as small gains stacked over months, which is a fair thing to know before week 2 instead of after it.

If your pain has outlived its tests and you are in Philadelphia, tell Dr. Ash the whole story, from the first day it hurt to the last normal result.

When should you see a doctor now?

Same-day evaluation, or an emergency department, is the right speed when pain travels with certain companions, because those combinations can mean infection, cancer, or nerve compression that will not wait for a methodical workup. The screening framework doctors use watches for:

• Fever or drenching night sweats along with the pain
• Night pain that wakes you, paired with weight loss you did not intend
• New weakness, numbness that is spreading, or new trouble with balance
• New loss of bladder or bowel control, or new numbness in the seat and inner thighs
• A history of cancer with new or changing pain
• Pain that begins after significant trauma, like a fall or a crash
• New significant pain starting after age 50, above all when any of the others come with it

For everything else, 3 months of persistent pain is the definition of chronic, and reaching that mark means a formal workup is due. You do not have to wait for it to be taken seriously, and if you are far past it, the workup is not early, it is owed.

with chronic pain, and it has recognized diagnoses, including chronic primary pain in ICD-11. - Pain runs on 3 mechanisms, nociceptive, neuropathic, and nociplastic, and standard labs and scans only detect the first 2. - Nociplastic pain is a positive diagnosis with published criteria: duration, distribution, hypersensitivity on examination, and companion symptoms, with normal tests built into the picture. - A careful workup reads the whole history, examines, then orders tests by pattern, and each normal result narrows the field by name. - Fever, unintended weight loss, night pain, new weakness, bladder or bowel changes, or a cancer history with new pain needs same-day evaluation.

Related at Fishtown Medicine

• Back pain and sciatica - the structural workup when pain maps to the spine
• Chest wall pain and costochondritis - chest pain you can reproduce by pressing, and the evaluation it still deserves
• Polymyalgia rheumatica - new shoulder and hip stiffness after 50, with high inflammation markers
• Small fiber neuropathy - burning pain that standard nerve tests miss
• When you never got better - pain and fatigue that started with an infection

Scientific References

1. Nicholas M, Vlaeyen JWS, Rief W, et al. "The IASP classification of chronic pain for ICD-11: chronic primary pain." Pain. 2019;160(1):28-37. DOI
2. Fitzcharles MA, Cohen SP, Clauw DJ, Littlejohn G, Usui C, Häuser W. "Nociplastic pain: towards an understanding of prevalent pain conditions." The Lancet. 2021;397(10289):2098-2110. DOI
3. Kosek E, Clauw D, Nijs J, et al. "Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system." Pain. 2021;162(11):2629-2634. Journal
4. Woolf CJ. "Central sensitization: implications for the diagnosis and treatment of pain." Pain. 2011;152(3 Suppl):S2-S15. ScienceDirect
5. Gracely RH, Petzke F, Wolf JM, Clauw DJ. "Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia." Arthritis & Rheumatism. 2002;46(5):1333-1343. Wiley
6. Lauria G, Hsieh ST, Johansson O, et al. "European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy." European Journal of Neurology. 2010;17(7). Wiley
7. Chou R, Qaseem A, Snow V, et al. "Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society." Annals of Internal Medicine. 2007;147(7):478-491. ACP Journals
8. Brinjikji W, Luetmer PH, Comstock B, et al. "Systematic Literature Review of Imaging Features of Spinal Degeneration in Asymptomatic Populations." American Journal of Neuroradiology. 2015;36(4):811-816. AJNR
9. Rikard SM, Strahan AE, Schmit KM, Guy GP. "Chronic Pain Among Adults - United States, 2019-2021." MMWR Morbidity and Mortality Weekly Report. 2023;72(15):379-385. PMC